| Year |
Citation |
Score |
| 2019 |
Di Meo A, Batruch I, Brown MD, Yang C, Finelli A, Jewett MAS, Diamandis EP, Yousef GM. Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass. The American Journal of Pathology. 189: 2366-2376. PMID 31761032 DOI: 10.1016/J.Ajpath.2019.08.015 |
0.475 |
|
| 2019 |
Di Meo A, Brown MD, Finelli A, Jewett MAS, Diamandis EP, Yousef GM. Prognostic Urinary miRNAs for the Assessment of Small Renal Masses. Clinical Biochemistry. PMID 31672647 DOI: 10.1016/J.Clinbiochem.2019.10.002 |
0.45 |
|
| 2019 |
Saleeb R, Kim SS, Ding Q, Scorilas A, Lin S, Khella HW, Boulos C, Ibrahim G, Yousef GM. The miR-200 family as prognostic markers in clear cell renal cell carcinoma. Urologic Oncology. PMID 31635993 DOI: 10.1016/J.Urolonc.2019.08.008 |
0.369 |
|
| 2019 |
Di Meo A, Batruch I, Brown MD, Yang C, Finelli A, Jewett MA, Diamandis EP, Yousef GM. Searching for Prognostic Biomarkers for Small Renal Masses in the Urinary Proteome. International Journal of Cancer. PMID 31465112 DOI: 10.1002/Ijc.32650 |
0.487 |
|
| 2019 |
Saleeb RM, Farag M, Ding Q, Downes M, Bjarnason G, Brimo F, Plant P, Rotondo F, Lichner Z, Finelli A, Yousef GM. Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells. The American Journal of Pathology. PMID 31381885 DOI: 10.1016/J.Ajpath.2019.07.002 |
0.339 |
|
| 2019 |
Pampalakis G, Zingkou E, Sidiropoulos KG, Diamandis EP, Zoumpourlis V, Yousef GM, Sotiropoulou G. Biochemical pathways mediated by KLK6 protease in breast cancer. Molecular Oncology. PMID 30980596 DOI: 10.1002/1878-0261.12493 |
0.502 |
|
| 2018 |
Lichner Z, Saleeb R, Butz H, Ding Q, Nofech-Mozes R, Riad S, Farag M, Varkouhi AK, Dos Santos CC, Kapus A, Yousef GM. Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201800596R. PMID 30148679 DOI: 10.1096/Fj.201800596R |
0.325 |
|
| 2018 |
Damayanti NP, Budka JA, Khella HWZ, Ferris MW, Ku SY, Kauffman EC, Wood AC, Ahmed K, Chintala VN, Adelaiye-Ogala R, Elbanna M, Orillion AR, Chintala S, Kao C, Linehan WM, ... Yousef GM, et al. Therapeutic targeting of TFE3/IRS-1/PI3K/mTOR axis in translocation renal cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30061365 DOI: 10.1158/1078-0432.Ccr-18-0269 |
0.353 |
|
| 2018 |
Saleeb RM, Farag M, Lichner Z, Brimo F, Bartlett J, Bjarnason G, Finelli A, Rontondo F, Downes MR, Yousef GM. Modulating ATP Binding Cassette (ABC) Transporters in Papillary Renal Cell Carcinoma Type 2 Enhances its Response to Targeted Molecular Therapy. Molecular Oncology. PMID 29896907 DOI: 10.1002/1878-0261.12346 |
0.324 |
|
| 2018 |
Di Meo A, Wang C, Cheng Y, Diamandis EP, Yousef GM. The miRNA-kallikrein interaction: a mosaic of epigenetic regulation in cancer. Biological Chemistry. PMID 29604203 DOI: 10.1515/Hsz-2018-0112 |
0.501 |
|
| 2018 |
Reuning U, Magdolen V, Courty Y, Clements JA, Yousef GM, Scorilas A, Talieri M, Diamandis EP. Manfred Schmitt (1947-2018). Biological Chemistry. PMID 29601294 DOI: 10.1515/Hsz-2018-0184 |
0.335 |
|
| 2018 |
Butz H, Ding Q, Nofech-Mozes R, Lichner Z, Ni H, Yousef GM. Elucidating mechanisms of sunitinib resistance in renal cancer: an integrated pathological-molecular analysis. Oncotarget. 9: 4661-4674. PMID 29435133 DOI: 10.18632/Oncotarget.23163 |
0.332 |
|
| 2018 |
Meo AD, Saleeb R, Wala SJ, Khella HW, Ding Q, Zhai H, Krishan K, Krizova A, Gabril M, Evans A, Brimo F, Pasic MD, Finelli A, Diamandis EP, Yousef GM. A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization. Oncotarget. 9: 2092-2104. PMID 29416756 DOI: 10.18632/Oncotarget.23162 |
0.448 |
|
| 2017 |
Saleeb RM, Brimo F, Farag M, Rompré-Brodeur A, Rotondo F, Beharry V, Wala S, Plant P, Downes MR, Pace K, Evans A, Bjarnason G, Bartlett JMS, Yousef GM. Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis. The American Journal of Surgical Pathology. PMID 28984673 DOI: 10.1097/Pas.0000000000000962 |
0.366 |
|
| 2017 |
Lichner Z, Mac-Way F, Yousef GM. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis. European Urology Focus. PMID 28847686 DOI: 10.1016/J.Euf.2017.08.003 |
0.32 |
|
| 2017 |
Di Meo A, Bartlett J, Cheng Y, Pasic MD, Yousef GM. Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Molecular Cancer. 16: 80. PMID 28410618 DOI: 10.1186/S12943-017-0644-5 |
0.392 |
|
| 2017 |
Khella HW, Daniel N, Youssef L, Scorilas A, Nofech-Mozes R, Mirham L, Krylov SN, Liandeau E, Krizova A, Finelli A, Cheng Y, Yousef GM. miR-10b is a prognostic marker in clear cell renal cell carcinoma. Journal of Clinical Pathology. PMID 28360191 DOI: 10.1136/Jclinpath-2017-204341 |
0.335 |
|
| 2017 |
Hu L, Stasheuski AS, Wegman DW, Wu N, Yang BB, Hayder H, Peng C, Liu SK, Yousef GM, Krylov SN. Accurate miRNA analysis in Crude Cell lysate by Capillary Electrophoresis-Based Hybridization Assay in Comparison with Quantitative Reverse Transcription-Polymerase Chain Reaction. Analytical Chemistry. PMID 28339187 DOI: 10.1021/Acs.Analchem.7B00707 |
0.302 |
|
| 2017 |
Meo AD, Hanna M, Saleeb R, Wala S, Krizova A, Gabril M, Zhai H, Pasic M, Evans A, Brimo F, Yousef G. Abstract 5447: A microRNA signature for the classification of renal cell carcinoma subtypes Cancer Research. 77: 5447-5447. DOI: 10.1158/1538-7445.Am2017-5447 |
0.31 |
|
| 2016 |
Saleeb RM, Plant P, Tawedrous E, Krizova A, Brimo F, Evans AJ, Wala SJ, Bartlett J, Ding Q, Boles D, Rotando F, Farag M, Yousef GM. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy. European Urology Focus. PMID 28753789 DOI: 10.1016/J.Euf.2016.09.002 |
0.337 |
|
| 2016 |
Butz H, Nofech-Mozes R, Ding Q, Khella HWZ, Szabó PM, Jewett M, Finelli A, Lee J, Ordon M, Stewart R, Krylov S, Yousef GM. Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma. European Urology Focus. 2: 210-218. PMID 28723537 DOI: 10.1016/J.Euf.2015.11.006 |
0.318 |
|
| 2016 |
Fendler A, Stephan C, Yousef GM, Kristiansen G, Jung K. The translational potential of microRNAs as biofluid markers of urological tumours. Nature Reviews. Urology. PMID 27804986 DOI: 10.1038/Nrurol.2016.193 |
0.372 |
|
| 2016 |
White-Al Habeeb N, Kulasingam V, Diamandis EP, Yousef GM, Tsongalis GJ, Vermeulen L, Zhu Z, Kamel-Reid S. The Use of Targeted Therapies for Precision Medicine in Oncology. Clinical Chemistry. PMID 27679436 DOI: 10.1373/Clinchem.2015.247882 |
0.462 |
|
| 2016 |
Prud'homme GJ, Glinka Y, Lichner Z, Yousef GM. Neuropilin-1 is a receptor for extracellular miRNA and AGO2/miRNA complexes and mediates the internalization of miRNAs that modulate cell function. Oncotarget. PMID 27486976 DOI: 10.18632/Oncotarget.10929 |
0.309 |
|
| 2016 |
Di Meo A, Batruch I, Yousef AG, Pasic MD, Diamandis EP, Yousef GM. An integrated proteomic and peptidomic assessment of the normal human urinome. Clinical Chemistry and Laboratory Medicine. PMID 27394047 DOI: 10.1515/Cclm-2016-0390 |
0.446 |
|
| 2016 |
Markou A, Zavridou M, Sourvinou I, Yousef G, Kounelis S, Malamos N, Georgoulias V, Lianidou E. Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients. Clinical Chemistry. PMID 27197674 DOI: 10.1373/Clinchem.2015.253716 |
0.356 |
|
| 2016 |
Di Meo A, Pasic MD, Yousef GM. Proteomics and peptidomics: moving toward precision medicine in urological malignancies. Oncotarget. PMID 27119500 DOI: 10.18632/Oncotarget.8931 |
0.361 |
|
| 2016 |
Sidiropoulos KG, Ding Q, Pampalakis G, White NM, Boulos P, Sotiropoulou G, Yousef GM. KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes. Molecular Oncology. PMID 27093921 DOI: 10.1016/J.Molonc.2016.03.008 |
0.411 |
|
| 2016 |
Nofech-Mozes R, Khella HW, Scorilas A, Youssef L, Krylov SN, Lianidou E, Sidiropoulos KG, Gabril M, Evans A, Yousef GM. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma. Cancer Medicine. 5: 656-64. PMID 26860079 DOI: 10.1002/Cam4.631 |
0.351 |
|
| 2015 |
Gabril M, Girgis H, Scorilas A, Rotondo F, Wala S, Bjarnason GA, Ding Q, Evans A, Tawedrous E, Pasic M, Finelli A, Al-Haddad S, Yousef GM. S100A11 is a potential prognostic marker for clear cell renal cell carcinoma. Clinical & Experimental Metastasis. PMID 26472670 DOI: 10.1007/S10585-015-9758-6 |
0.398 |
|
| 2015 |
Luchini C, Veronese N, Solmi M, Cho H, Kim JH, Chou A, Gill AJ, Faraj SF, Chaux A, Netto GJ, Nakayama K, Kyo S, Lee SY, Kim DW, Yousef GM, et al. Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis. Oncotarget. PMID 26384299 DOI: 10.18632/Oncotarget.5142 |
0.361 |
|
| 2015 |
Kolin DL, Sy K, Rotondo F, Bassily MN, Kovacs K, Brezden-Masley C, Streutker CJ, Yousef GM. Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26224476 DOI: 10.1007/S13277-015-3802-7 |
0.368 |
|
| 2015 |
Khella HW, Butz H, Ding Q, Rotondo F, Evans KR, Kupchak P, Dharsee M, Latif A, Pasic MD, Lianidou E, Bjarnason GA, Yousef GM. miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26201448 DOI: 10.1038/Mt.2015.129 |
0.358 |
|
| 2015 |
Yousef GM. Personalized Medicine in Kidney Cancer: Learning How to Walk Before We Run. European Urology. 68: 1021-2. PMID 26166627 DOI: 10.1016/J.Eururo.2015.06.037 |
0.415 |
|
| 2015 |
Wala SJ, Karamchandani JR, Saleeb R, Evans A, Ding Q, Ibrahim R, Jewett M, Pasic M, Finelli A, Pace K, Lianidou E, Yousef GM. An integrated genomic analysis of papillary renal cell carcinoma type 1 uncovers the role of focal adhesion and extracellular matrix pathways. Molecular Oncology. PMID 26051997 DOI: 10.1016/J.Molonc.2015.04.007 |
0.349 |
|
| 2015 |
White-Al Habeeb NM, Di Meo A, Scorilas A, Rotondo F, Masui O, Seivwright A, Gabril M, Girgis AH, Jewett MA, Yousef GM. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma. Clinical & Experimental Metastasis. 32: 531-41. PMID 26037892 DOI: 10.1007/S10585-015-9725-2 |
0.381 |
|
| 2015 |
Lichner Z, Ding Q, Samaan S, Saleh C, Nasser A, Al-Haddad S, Samuel JN, Fleshner NE, Stephan C, Jung K, Yousef GM. miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways. The Journal of Pathology. PMID 26011734 DOI: 10.1002/Path.4568 |
0.337 |
|
| 2015 |
Butz H, Szabó PM, Khella HW, Nofech-Mozes R, Patocs A, Yousef GM. miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1. Oncotarget. 6: 12543-57. PMID 26002553 DOI: 10.18632/Oncotarget.3815 |
0.339 |
|
| 2015 |
Yousef GM. miRSNP-Based Approach Identifies a miRNA That Regulates Prostate-Specific Antigen in an Allele-Specific Manner. Cancer Discovery. 5: 351-2. PMID 25847955 DOI: 10.1158/2159-8290.Cd-15-0230 |
0.322 |
|
| 2015 |
Papadopoulos EI, Yousef GM, Scorilas A. Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 36: 3197-207. PMID 25833690 DOI: 10.1007/S13277-014-2190-8 |
0.39 |
|
| 2015 |
Papadopoulos EI, Yousef GM, Scorilas A. Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 70: 33-40. PMID 25776476 DOI: 10.1016/J.Biopha.2014.12.043 |
0.337 |
|
| 2015 |
Karamchandani JR, Gabril MY, Ibrahim R, Scorilas A, Filter E, Finelli A, Lee JY, Ordon M, Pasic M, Romaschin AD, Yousef GM. Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma. Human Pathology. 46: 673-80. PMID 25704627 DOI: 10.1016/J.Humpath.2014.11.007 |
0.364 |
|
| 2015 |
Grin A, Samaan S, Tripathi M, Rotondo F, Kovacs K, Bassily MN, Yousef GM. Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma. Human Pathology. 46: 541-8. PMID 25649006 DOI: 10.1016/J.Humpath.2014.12.005 |
0.42 |
|
| 2015 |
Khella HW, Scorilas A, Mozes R, Mirham L, Lianidou E, Krylov SN, Lee JY, Ordon M, Stewart R, Jewett MA, Yousef GM. Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma. The American Journal of Pathology. 185: 693-703. PMID 25572155 DOI: 10.1016/J.Ajpath.2014.11.017 |
0.334 |
|
| 2015 |
Samaan S, Khella HW, Girgis A, Scorilas A, Lianidou E, Gabril M, Krylov SN, Jewett M, Bjarnason GA, El-said H, Yousef GM. miR-210 is a prognostic marker in clear cell renal cell carcinoma. The Journal of Molecular Diagnostics : Jmd. 17: 136-44. PMID 25555365 DOI: 10.1016/J.Jmoldx.2014.10.005 |
0.391 |
|
| 2015 |
Rotondo F, Di Ieva A, Kovacs K, Cusimano MD, Syro LV, Diamandis EP, Yousef GM. Human kallikrein 10 in surgically removed human pituitary adenomas. Hormones (Athens, Greece). 14: 272-9. PMID 25553760 DOI: 10.14310/Horm.2002.1558 |
0.437 |
|
| 2015 |
Di Meo A, Rotondo F, Kovacs K, Cusimano MD, Syro LV, Di Ieva A, Diamandis EP, Yousef GM. Human Kallikrein 10 Expression in Surgically Removed Human Pituitary Corticotroph Adenomas: An Immunohistochemical Study. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 23: 433-7. PMID 25517869 DOI: 10.1097/Pai.0000000000000108 |
0.463 |
|
| 2015 |
Lichner Z, Saleh C, Subramaniam V, Seivwright A, Prud'homme GJ, Yousef GM. miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell/ tumor initiating cell properties. Oncotarget. 6: 5567-81. PMID 25011053 DOI: 10.18632/Oncotarget.1901 |
0.387 |
|
| 2014 |
Kolin DL, Sy K, Rotondo F, Bassily MN, Kovacs K, Brezden-Masley C, Streutker CJ, Yousef GM. Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer. Biological Chemistry. 395: 1087-93. PMID 25153389 DOI: 10.1515/Hsz-2014-0143 |
0.398 |
|
| 2014 |
Samaan S, Lichner Z, Ding Q, Saleh C, Samuel J, Streutker C, Yousef GM. Kallikreins are involved in an miRNA network that contributes to prostate cancer progression. Biological Chemistry. 395: 991-1001. PMID 25153383 DOI: 10.1515/Hsz-2013-0288 |
0.409 |
|
| 2014 |
Yousef GM, Pasic M, Diamandis EP. Highlight: the 5th International Symposium on Kallikreins and Kallikrein-Related Peptidases. Biological Chemistry. 395: 913-4. PMID 25153379 DOI: 10.1515/Hsz-2014-0228 |
0.346 |
|
| 2014 |
Butz H, Szabó PM, Nofech-Mozes R, Rotondo F, Kovacs K, Mirham L, Girgis H, Boles D, Patocs A, Yousef GM. Integrative bioinformatics analysis reveals new prognostic biomarkers of clear cell renal cell carcinoma. Clinical Chemistry. 60: 1314-26. PMID 25139457 DOI: 10.1373/Clinchem.2014.225854 |
0.319 |
|
| 2014 |
Girgis H, Masui O, White NM, Scorilas A, Rotondo F, Seivwright A, Gabril M, Filter ER, Girgis AH, Bjarnason GA, Jewett MA, Evans A, Al-Haddad S, Siu KM, Yousef GM. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Molecular Cancer. 13: 101. PMID 24885701 DOI: 10.1186/1476-4598-13-101 |
0.347 |
|
| 2014 |
Di Ieva A, Butz H, Niamah M, Rotondo F, De Rosa S, Sav A, Yousef GM, Kovacs K, Cusimano MD. MicroRNAs as biomarkers in pituitary tumors. Neurosurgery. 75: 181-9; discussion 18. PMID 24739366 DOI: 10.1227/Neu.0000000000000369 |
0.339 |
|
| 2014 |
White NM, Masui O, Desouza LV, Krakovska O, Metias S, Romaschin AD, Honey RJ, Stewart R, Pace K, Lee J, Jewett MA, Bjarnason GA, Siu KW, Yousef GM. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma. Oncotarget. 5: 506-18. PMID 24504108 DOI: 10.18632/Oncotarget.1529 |
0.359 |
|
| 2014 |
White NM, Newsted DW, Masui O, Romaschin AD, Siu KW, Yousef GM. Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 1833-46. PMID 24136743 DOI: 10.1007/S13277-013-1245-6 |
0.36 |
|
| 2014 |
Markou A, Yousef GM, Stathopoulos E, Georgoulias V, Lianidou E. Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up. Clinical Chemistry. 60: 197-205. PMID 24132943 DOI: 10.1373/Clinchem.2013.210542 |
0.392 |
|
| 2013 |
Schaefer A, Saleh C, Nasser A, Boles D, Al-Haddad S, Kupchak P, Dharsee M, Nuin PS, Evans KR, Jung K, Stephan C, Fleshner NE, Yousef GM. Use of microRNA signature to distinguish early from late biochemical failure in prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 194. PMID 28137175 DOI: 10.1200/Jco.2013.31.6_Suppl.194 |
0.351 |
|
| 2013 |
Masui O, DeSouza L, Krakovska O, Matta A, Bjarnason GA, Siu KW, Yousef GM. Relative quantification of protein expression in metastatic renal cell carcinoma using iTRAQ LC-MS/MS analysis reveals galectin-1 as a potential prognostic marker and therapeutic target. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 412. PMID 28137159 DOI: 10.1200/Jco.2013.31.6_Suppl.412 |
0.364 |
|
| 2013 |
Saleh C, Subramaniam V, Prud'homme G, Yousef GM. Involvement of miRNAs in the formation and maintenance of self-renewing kidney cancer spheres with stem cell properties. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 463. PMID 28137028 DOI: 10.1200/Jco.2013.31.6_Suppl.463 |
0.358 |
|
| 2013 |
Schmitt M, Magdolen V, Yang F, Kiechle M, Bayani J, Yousef GM, Scorilas A, Diamandis EP, Dorn J. Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies. Radiology and Oncology. 47: 319-29. PMID 24294176 DOI: 10.2478/Raon-2013-0053 |
0.681 |
|
| 2013 |
Fendler A, Jung M, Stephan C, Erbersdobler A, Jung K, Yousef GM. The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1. Plos One. 8: e80807. PMID 24260486 DOI: 10.1371/Journal.Pone.0080807 |
0.338 |
|
| 2013 |
Ghasemi F, Wegman DW, Kanoatov M, Yang BB, Liu SK, Yousef GM, Krylov SN. Improvements to direct quantitative analysis of multiple microRNAs facilitating faster analysis. Analytical Chemistry. 85: 10062-6. PMID 24127917 DOI: 10.1021/Ac402812F |
0.31 |
|
| 2013 |
Lichner Z, Fendler A, Saleh C, Nasser AN, Boles D, Al-Haddad S, Kupchak P, Dharsee M, Nuin PS, Evans KR, Jung K, Stephan C, Fleshner NE, Yousef GM. MicroRNA signature helps distinguish early from late biochemical failure in prostate cancer. Clinical Chemistry. 59: 1595-603. PMID 23958847 DOI: 10.1373/Clinchem.2013.205450 |
0.364 |
|
| 2013 |
Dorn J, Bayani J, Yousef GM, Yang F, Magdolen V, Kiechle M, Diamandis EP, Schmitt M. Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies. Thrombosis and Haemostasis. 110: 408-22. PMID 23765253 DOI: 10.1160/Th13-03-0206 |
0.693 |
|
| 2013 |
Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 81: 388-96. PMID 23756108 DOI: 10.1016/J.Lungcan.2013.05.007 |
0.311 |
|
| 2013 |
Khella HW, Bakhet M, Allo G, Jewett MA, Girgis AH, Latif A, Girgis H, Von Both I, Bjarnason GA, Yousef GM. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma. Carcinogenesis. 34: 2231-9. PMID 23715501 DOI: 10.1093/Carcin/Bgt184 |
0.351 |
|
| 2013 |
Pasic MD, Yousef GM, Diamandis EP. The proteomic revolution in laboratory medicine. Clinical Biochemistry. 46: 397-8. PMID 23497914 DOI: 10.1016/J.Clinbiochem.2013.02.012 |
0.367 |
|
| 2013 |
Lichner Z, Scorilas A, White NM, Girgis AH, Rotstein L, Wiegand KC, Latif A, Chow C, Huntsman D, Yousef GM. The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma. The American Journal of Pathology. 182: 1163-70. PMID 23416164 DOI: 10.1016/J.Ajpath.2013.01.007 |
0.417 |
|
| 2013 |
Khella HW, Bakhet M, Lichner Z, Romaschin AD, Jewett MA, Yousef GM. MicroRNAs in kidney disease: an emerging understanding. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 61: 798-808. PMID 23219107 DOI: 10.1053/J.Ajkd.2012.09.018 |
0.329 |
|
| 2013 |
Masui O, White NM, DeSouza LV, Krakovska O, Matta A, Metias S, Khalil B, Romaschin AD, Honey RJ, Stewart R, Pace K, Bjarnason GA, Siu KW, Yousef GM. Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance. Molecular & Cellular Proteomics : McP. 12: 132-44. PMID 23082029 DOI: 10.1074/Mcp.M112.020701 |
0.4 |
|
| 2013 |
Markou AN, Yousef GM, Liang Y, Stathopoulos E, Georgoulias V, Lianidou ES. Abstract 5341: Clinical relevance of metastasis-related miRNAs in early breast cancer. Cancer Research. 73: 5341-5341. DOI: 10.1158/1538-7445.Am2013-5341 |
0.346 |
|
| 2012 |
Bjarnason GA, White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Jewett MA, Evans A, Gabril M, Yousef GM. Tumor suppressor effects for miR-215 identified through use of miRNA profiling in metastatic renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 392. PMID 27968234 DOI: 10.1200/Jco.2012.30.5_Suppl.392 |
0.397 |
|
| 2012 |
Bjarnason GA, Lichner Z, Mejia-Guerrero S, Ignacak M, Krizova A, Bao TT, Girgis A, Youssef YM, Yousef GM. Pleotrophic action of renal cell carcinoma: Dysregulated microRNAs on hypoxia-related signaling pathways. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 428. PMID 27968082 DOI: 10.1200/Jco.2012.30.5_Suppl.428 |
0.368 |
|
| 2012 |
Girgis AH, Iakovlev VV, Beheshti B, Bayani J, Squire JA, Bui A, Mankaruos M, Youssef Y, Khalil B, Khella H, Pasic M, Yousef GM. Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma. Cancer Research. 72: 5273-84. PMID 22926558 DOI: 10.1158/0008-5472.Can-12-0656 |
0.642 |
|
| 2012 |
Faragalla H, Youssef YM, Scorilas A, Khalil B, White NM, Mejia-Guerrero S, Khella H, Jewett MA, Evans A, Lichner Z, Bjarnason G, Sugar L, Attalah MI, Yousef GM. The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. The Journal of Molecular Diagnostics : Jmd. 14: 385-92. PMID 22580180 DOI: 10.1016/J.Jmoldx.2012.02.003 |
0.333 |
|
| 2012 |
White NM, Youssef YM, Fendler A, Stephan C, Jung K, Yousef GM. The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer. Biological Chemistry. 393: 379-89. PMID 22505520 DOI: 10.1515/Hsz-2011-0246 |
0.376 |
|
| 2012 |
Pasic MD, Olkhov E, Bapat B, Yousef GM. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there. Biological Chemistry. 393: 319-30. PMID 22505515 DOI: 10.1515/Hsz-2011-0273 |
0.421 |
|
| 2012 |
Petraki C, Youssef YM, Dubinski W, Lichner Z, Scorilas A, Pasic MD, Komborozos V, Khalil B, Streutker C, Diamandis EP, Yousef GM. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 33: 1209-14. PMID 22437349 DOI: 10.1007/S13277-012-0368-5 |
0.504 |
|
| 2012 |
Lichner Z, Mejia-Guerrero S, Ignacak M, Krizova A, Bao TT, Girgis AH, Youssef YM, Yousef GM. Pleiotropic action of renal cell carcinoma-dysregulated miRNAs on hypoxia-related signaling pathways. The American Journal of Pathology. 180: 1675-87. PMID 22326755 DOI: 10.1016/J.Ajpath.2011.12.030 |
0.355 |
|
| 2012 |
Yousef GM. Personalized cancer genomics: the road map to clinical implementation. Clinical Chemistry. 58: 661-3. PMID 22322979 DOI: 10.1373/Clinchem.2011.181073 |
0.323 |
|
| 2012 |
Petraki C, Dubinski W, Scorilas A, Saleh C, Pasic MD, Komborozos V, Khalil B, Gabril MY, Streutker C, Diamandis EP, Yousef GM. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer. Pathology, Research and Practice. 208: 104-8. PMID 22285222 DOI: 10.1016/J.Prp.2011.12.010 |
0.512 |
|
| 2012 |
Dubinski W, Gabril M, Iakovlev VV, Scorilas A, Youssef YM, Faragalla H, Kovacs K, Rotondo F, Metias S, Arsanious A, Plotkin A, Girgis AH, Streutker CJ, Yousef GM. Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis. Human Pathology. 43: 1037-43. PMID 22204709 DOI: 10.1016/J.Humpath.2011.08.012 |
0.318 |
|
| 2012 |
Khella HW, White NM, Faragalla H, Gabril M, Boazak M, Dorian D, Khalil B, Antonios H, Bao TT, Pasic MD, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, ... Yousef GM, et al. Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 33: 131-40. PMID 22086373 DOI: 10.1007/S13277-011-0255-5 |
0.375 |
|
| 2012 |
Iakovlev VV, Gabril M, Dubinski W, Scorilas A, Youssef YM, Faragalla H, Kovacs K, Rotondo F, Metias S, Arsanious A, Plotkin A, Girgis AH, Streutker CJ, Yousef GM. Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study. Laboratory Investigation; a Journal of Technical Methods and Pathology. 92: 46-56. PMID 22042086 DOI: 10.1038/Labinvest.2011.153 |
0.338 |
|
| 2012 |
Yousef GM, Chan SM, White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Jewett MAS, Evans A, Gabril MY, Bjarnason GA. Use of miRNA profiling in metastatic renal cell carcinoma to reveal a tumor suppressor effect for mir-215. Journal of Clinical Oncology. 30: 4633-4633. DOI: 10.1200/Jco.2012.30.15_Suppl.4633 |
0.356 |
|
| 2012 |
Chan SM, Sherman CG, Gabril MY, Zbieranowski IJ, Sugar LM, Yousef GM, Bjarnason GA. Xp11.2 translocations in adult renal cell carcinomas with clear cell and papillary features. Journal of Clinical Oncology. 30: 4613-4613. DOI: 10.1200/Jco.2012.30.15_Suppl.4613 |
0.324 |
|
| 2012 |
Markou AN, Vorkas PA, Sourvinou I, Yousef GM, Lianidou ES. Abstract 4139: Clinical evaluation of microRNA expression profiling in non-small cell lung cancer Cancer Research. 72: 4139-4139. DOI: 10.1158/1538-7445.Am2012-4139 |
0.357 |
|
| 2011 |
White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Evans AJ, Gabril M, Yousef GM. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215. British Journal of Cancer. 105: 1741-9. PMID 22033272 DOI: 10.1038/Bjc.2011.401 |
0.389 |
|
| 2011 |
White NM, Bao TT, Grigull J, Youssef YM, Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Yousef GM. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. The Journal of Urology. 186: 1077-83. PMID 21784468 DOI: 10.1016/J.Juro.2011.04.110 |
0.38 |
|
| 2011 |
Fendler A, Jung M, Stephan C, Honey RJ, Stewart RJ, Pace KT, Erbersdobler A, Samaan S, Jung K, Yousef GM. miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression. International Journal of Oncology. 39: 1183-92. PMID 21769427 DOI: 10.3892/Ijo.2011.1128 |
0.406 |
|
| 2011 |
Fendler A, Stephan C, Yousef GM, Jung K. MicroRNAs as regulators of signal transduction in urological tumors. Clinical Chemistry. 57: 954-68. PMID 21632885 DOI: 10.1373/Clinchem.2010.157727 |
0.331 |
|
| 2011 |
Youssef YM, White NM, Grigull J, Krizova A, Samy C, Mejia-Guerrero S, Evans A, Yousef GM. Accurate molecular classification of kidney cancer subtypes using microRNA signature. European Urology. 59: 721-30. PMID 21272993 DOI: 10.1016/J.Eururo.2011.01.004 |
0.359 |
|
| 2011 |
White NM, Fatoohi E, Metias M, Jung K, Stephan C, Yousef GM. Metastamirs: a stepping stone towards improved cancer management. Nature Reviews. Clinical Oncology. 8: 75-84. PMID 21045789 DOI: 10.1038/Nrclinonc.2010.173 |
0.366 |
|
| 2011 |
Yousef G, Diamandis E. KLK5 (Kallikrein-related peptidase 5) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/44470 |
0.427 |
|
| 2011 |
Schaefer A, Jung M, Stephan C, Busch J, Erbersdobler A, Yousef G, Jung K. 1289 MIR-96 REGULATES APOPTOSIS IN PROSTATE CANCER VIA INHIBITION OF FOXO1 Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.975 |
0.325 |
|
| 2010 |
White NM, Yousef GM. MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer. Bmc Medicine. 8: 65. PMID 20964839 DOI: 10.1186/1741-7015-8-65 |
0.347 |
|
| 2010 |
Diamandis M, White NM, Yousef GM. Personalized medicine: marking a new epoch in cancer patient management. Molecular Cancer Research : McR. 8: 1175-87. PMID 20693306 DOI: 10.1158/1541-7786.Mcr-10-0264 |
0.328 |
|
| 2010 |
Schaefer A, Stephan C, Busch J, Yousef GM, Jung K. Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nature Reviews. Urology. 7: 286-97. PMID 20368743 DOI: 10.1038/Nrurol.2010.45 |
0.327 |
|
| 2010 |
White NMA, Chow TFF, Mejia-Guerrero S, Diamandis M, Rofael Y, Faragalla H, Mankaruous M, Gabril M, Girgis A, Yousef GM. Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer British Journal of Cancer. 102: 1244-1253. PMID 20354523 DOI: 10.1038/Sj.Bjc.6605634 |
0.379 |
|
| 2010 |
White NM, Bui A, Mejia-Guerrero S, Chao J, Soosaipillai A, Youssef Y, Mankaruos M, Honey RJ, Stewart R, Pace KT, Sugar L, Diamandis EP, Doré J, Yousef GM. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs. Biological Chemistry. 391: 411-23. PMID 20180642 DOI: 10.1515/Bc.2010.041 |
0.536 |
|
| 2010 |
Gabril M, White NM, Moussa M, Chow TF, Metias SM, Fatoohi E, Yousef GM. Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications. Biological Chemistry. 391: 403-9. PMID 20128686 DOI: 10.1515/Bc.2010.025 |
0.397 |
|
| 2010 |
Chow TF, Mankaruos M, Scorilas A, Youssef Y, Girgis A, Mossad S, Metias S, Rofael Y, Honey RJ, Stewart R, Pace KT, Yousef GM. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. The Journal of Urology. 183: 743-51. PMID 20022054 DOI: 10.1016/J.Juro.2009.09.086 |
0.345 |
|
| 2010 |
Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, Stewart R, Pace KT, Yousef GM. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clinical Biochemistry. 43: 150-8. PMID 19646430 DOI: 10.1016/J.Clinbiochem.2009.07.020 |
0.409 |
|
| 2010 |
Diamandis M, Chow T, Rofael Y, White N, Faragalla H, Mankaruous M, Girgis A, Yousef G. Dysregulated microRNAs (miRNAs) control kallikrein (KLK) gene expression in ovarian cancer Clinical Biochemistry. 43: 787. DOI: 10.1016/J.Clinbiochem.2010.04.042 |
0.397 |
|
| 2009 |
White NM, Mathews M, Yousef GM, Prizada A, Fontaine D, Ghatage P, Popadiuk C, Dawson L, Doré JJ. Human kallikrein related peptidases 6 and 13 in combination withCA125 is a more sensitive test for ovarian cancer than CA125 alone. Cancer Biomarkers : Section a of Disease Markers. 5: 279-87. PMID 20037204 DOI: 10.3233/Cbm-2009-0113 |
0.367 |
|
| 2009 |
Yousef GM, Diamandis EP. The human kallikrein gene family: new biomarkers for ovarian cancer. Cancer Treatment and Research. 149: 165-87. PMID 19763436 DOI: 10.1007/978-0-387-98094-2_8 |
0.504 |
|
| 2009 |
Metias SM, Lianidou E, Yousef GM. MicroRNAs in clinical oncology: At the crossroads between promises and problems Journal of Clinical Pathology. 62: 771-776. PMID 19734473 DOI: 10.1136/Jcp.2009.064717 |
0.359 |
|
| 2009 |
White NM, Mathews M, Yousef GM, Prizada A, Popadiuk C, Doré JJ. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma. British Journal of Cancer. 101: 1107-13. PMID 19707197 DOI: 10.1038/Sj.Bjc.6605280 |
0.451 |
|
| 2009 |
Angelopoulou K, Prassas I, Yousef GM. The canine kallikrein-related peptidase 14: structural characterization, alternative splicing and differential expression in mammary cancer. Gene. 446: 68-74. PMID 19619623 DOI: 10.1016/J.Gene.2009.07.007 |
0.687 |
|
| 2009 |
Siu KW, DeSouza LV, Scorilas A, Romaschin AD, Honey RJ, Stewart R, Pace K, Youssef Y, Chow TF, Yousef GM. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. Journal of Proteome Research. 8: 3797-807. PMID 19610612 DOI: 10.1021/Pr800389E |
0.39 |
|
| 2009 |
Arsanious A, Bjarnason GA, Yousef GM. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma. Molecular Cancer. 8: 20. PMID 19291329 DOI: 10.1186/1476-4598-8-20 |
0.352 |
|
| 2009 |
Romaschin AD, Youssef Y, Chow TF, Siu KW, DeSouza LV, Honey RJ, Stewart R, Pace KT, Yousef GM. Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins. Biological Chemistry. 390: 125-35. PMID 19090715 DOI: 10.1515/Bc.2009.013 |
0.367 |
|
| 2008 |
Yousef GM. microRNAs: a new frontier in kallikrein research. Biological Chemistry. 389: 689-94. PMID 18627305 DOI: 10.1515/Bc.2008.068 |
0.371 |
|
| 2008 |
Chow TF, Crow M, Earle T, El-Said H, Diamandis EP, Yousef GM. Kallikreins as microRNA targets: an in silico and experimental-based analysis. Biological Chemistry. 389: 731-8. PMID 18627289 DOI: 10.1515/Bc.2008.071 |
0.471 |
|
| 2006 |
Lundwall A, Band V, Blaber M, Clements JA, Courty Y, Diamandis EP, Fritz H, Lilja H, Malm J, Maltais LJ, Olsson AY, Petraki C, Scorilas A, Sotiropoulou G, Stenman UH, ... ... Yousef GM, et al. A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Biological Chemistry. 387: 637-41. PMID 16800724 DOI: 10.1515/Bc.2006.082 |
0.374 |
|
| 2006 |
Stephan C, Jung K, Nakamura T, Yousef GM, Kristiansen G, Diamandis EP. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer. International Journal of Urology : Official Journal of the Japanese Urological Association. 13: 238-43. PMID 16643616 DOI: 10.1111/J.1442-2042.2006.01276.X |
0.41 |
|
| 2006 |
Petraki CD, Gregorakis AK, Vaslamatzis MM, Papanastasiou PA, Yousef GM, Levesque MA, Diamandis EP. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 27: 1-7. PMID 16340244 DOI: 10.1159/000090150 |
0.502 |
|
| 2005 |
Yousef GM, Ejeckam GC, Best LM, Diamandis EP. Collecting duct carcinoma associated with oncocytoma. International Braz J Urol : Official Journal of the Brazilian Society of Urology. 31: 465-7; discussion 46. PMID 16255793 DOI: 10.1590/S1677-55382005000500008 |
0.353 |
|
| 2005 |
Stephan C, Jung K, Soosaipillai A, Yousef GM, Cammann H, Meyer H, Xu C, Diamandis EP. Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection. Bju International. 96: 521-7. PMID 16104903 DOI: 10.1111/J.1464-410X.2005.05677.X |
0.365 |
|
| 2005 |
Yousef GM, White NM, Michael IP, Cho JC, Robb JD, Kurlender L, Khan S, Diamandis EP. Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 26: 227-35. PMID 16103744 DOI: 10.1159/000087377 |
0.518 |
|
| 2005 |
Yousef GM, Obiezu CV, Luo LY, Magklara A, Borgoño CA, Kishi T, Memari N, Michael lP, Sidiropoulos M, Kurlender L, Economopolou K, Kapadia C, Komatsu N, Petraki C, Elliott M, et al. Human tissue kallikreins: from gene structure to function and clinical applications. Advances in Clinical Chemistry. 39: 11-79. PMID 16013667 DOI: 10.1016/S0065-2423(04)39002-5 |
0.571 |
|
| 2005 |
Kurlender L, Borgono C, Michael IP, Obiezu C, Elliott MB, Yousef GM, Diamandis EP. A survey of alternative transcripts of human tissue kallikrein genes. Biochimica Et Biophysica Acta. 1755: 1-14. PMID 15878240 DOI: 10.1016/J.Bbcan.2005.02.001 |
0.407 |
|
| 2005 |
Michael IP, Kurlender L, Memari N, Yousef GM, Du D, Grass L, Stephan C, Jung K, Diamandis EP. Intron retention: a common splicing event within the human kallikrein gene family. Clinical Chemistry. 51: 506-15. PMID 15650036 DOI: 10.1373/Clinchem.2004.042341 |
0.436 |
|
| 2004 |
Yousef GM, Borgoño CA, White NM, Robb JD, Michael IP, Oikonomopoulou K, Khan S, Diamandis EP. In silico analysis of the human kallikrein gene 6. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 25: 282-9. PMID 15627893 DOI: 10.1159/000081393 |
0.504 |
|
| 2004 |
Yousef GM, White NM, Kurlender L, Michael I, Memari N, Robb JD, Katsaros D, Stephan C, Jung K, Diamandis EP. The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 25: 221-7. PMID 15627884 DOI: 10.1159/000081384 |
0.486 |
|
| 2004 |
Yousef GM, Borgono CA, Michael IP, Diamandis EP. Cloning of a kallikrein pseudogene. Clinical Biochemistry. 37: 961-7. PMID 15498522 DOI: 10.1016/J.Clinbiochem.2004.07.012 |
0.448 |
|
| 2004 |
Kurlender L, Yousef GM, Memari N, Robb JD, Michael IP, Borgoño C, Katsaros D, Stephan C, Jung K, Diamandis EP. Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 25: 149-56. PMID 15361712 DOI: 10.1159/000079147 |
0.558 |
|
| 2004 |
Yousef GM, Borgoño CA, Michael IP, Davidian C, Stephan C, Jung K, Diamandis EP. Molecular cloning of a new gene which is differentially expressed in breast and prostate cancers. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 25: 122-33. PMID 15361709 DOI: 10.1159/000079144 |
0.452 |
|
| 2004 |
Yousef GM, Elliott MB, Kopolovic AD, Serry E, Diamandis EP. Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases. Biochimica Et Biophysica Acta. 1698: 77-86. PMID 15063317 DOI: 10.1016/J.Bbapap.2003.10.008 |
0.338 |
|
| 2004 |
Yousef GM, Borgoño CA, Popalis C, Yacoub GM, Polymeris ME, Soosaipillai A, Diamandis EP. In-silico analysis of kallikrein gene expression in pancreatic and colon cancers. Anticancer Research. 24: 43-51. PMID 15015574 |
0.465 |
|
| 2004 |
Diamandis EP, Yousef GM, Olsson AY. An update on human and mouse glandular kallikreins. Clinical Biochemistry. 37: 258-60. PMID 15003726 DOI: 10.1016/J.Clinbiochem.2003.12.013 |
0.451 |
|
| 2004 |
Yousef GM, Yacoub GM, Polymeris ME, Popalis C, Soosaipillai A, Diamandis EP. Kallikrein gene downregulation in breast cancer British Journal of Cancer. 90: 167-172. PMID 14710225 DOI: 10.1038/sj.bjc.6601451 |
0.451 |
|
| 2004 |
Kapadia C, Yousef GM, Mellati AA, Magklara A, Wasney GA, Diamandis EP. Complex formation between human kallikrein 13 and serum protease inhibitors. Clinica Chimica Acta; International Journal of Clinical Chemistry. 339: 157-67. PMID 14687906 DOI: 10.1016/J.Cccn.2003.10.009 |
0.456 |
|
| 2004 |
Stephan C, Yousef GM, Scorilas A, Jung K, Jung M, Kristiansen G, Hauptmann S, Kishi T, Nakamura T, Loening SA, Diamandis EP. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. The Journal of Urology. 171: 187-91. PMID 14665873 DOI: 10.1097/01.Ju.0000101622.74236.94 |
0.452 |
|
| 2004 |
Yousef GM, White NMA, Golmakani N, Louhimo J, Song L, Yan W, Deng M, Song S, Zhang J, Zhao T, Omidfar K, Rasaee MJ, Modjtahedi H, Forouzandeh M, Taghikhani M, et al. Contents Vol. 25, 2004 Tumor Biology. 25: 341-342. DOI: 10.1159/000083075 |
0.336 |
|
| 2004 |
Yousef GM, White NMA, Golmakani N, Louhimo J, Song L, Yan W, Deng M, Song S, Zhang J, Zhao T, Omidfar K, Rasaee MJ, Modjtahedi H, Forouzandeh M, Taghikhani M, et al. Subject Index Vol. 25, 2004 Tumor Biology. 25: 339-340. DOI: 10.1159/000083074 |
0.342 |
|
| 2003 |
Diamandis EP, Borgoño CA, Scorilas A, Yousef GM, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 24: 299-309. PMID 15004490 DOI: 10.1159/000076462 |
0.514 |
|
| 2003 |
Borgoño CA, Grass L, Soosaipillai A, Yousef GM, Petraki CD, Howarth DH, Fracchioli S, Katsaros D, Diamandis EP. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. Cancer Research. 63: 9032-41. PMID 14695222 |
0.476 |
|
| 2003 |
Yousef GM, Diamandis EP. An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers. Clinical Biochemistry. 36: 443-52. PMID 12951170 DOI: 10.1016/S0009-9120(03)00055-9 |
0.453 |
|
| 2003 |
Yousef GM, Scorilas A, Katsaros D, Fracchioli S, Iskander L, Borgono C, Rigault de la Longrais IA, Puopolo M, Massobrio M, Diamandis EP. Prognostic value of the human kallikrein gene 15 expression in ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 3119-26. PMID 12915603 DOI: 10.1200/Jco.2003.09.111 |
0.486 |
|
| 2003 |
Yousef GM, Kapadia C, Polymeris ME, Borgono C, Hutchinson S, Wasney GA, Soosaipillai A, Diamandis EP. The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids. Biochimica Et Biophysica Acta. 1628: 88-96. PMID 12890555 DOI: 10.1016/S0167-4781(03)00116-7 |
0.467 |
|
| 2003 |
Yousef GM, Diamandis EP. Tissue kallikreins: new players in normal and abnormal cell growth? Thrombosis and Haemostasis. 90: 7-16. PMID 12876620 DOI: 10.1267/THRO03010007 |
0.461 |
|
| 2003 |
Yousef GM, Polymeris ME, Grass L, Soosaipillai A, Chan PC, Scorilas A, Borgoño C, Harbeck N, Schmalfeldt B, Dorn J, Schmitt M, Diamandis EP. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Cancer Research. 63: 3958-65. PMID 12873991 |
0.464 |
|
| 2003 |
Yousef GM, Stephan C, Scorilas A, Ellatif MA, Jung K, Kristiansen G, Jung M, Polymeris ME, Diamandis EP. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues. The Prostate. 56: 287-92. PMID 12858357 DOI: 10.1002/Pros.10263 |
0.563 |
|
| 2003 |
Borgoño CA, Fracchioli S, Yousef GM, Rigault de la Longrais IA, Luo LY, Soosaipillai A, Puopolo M, Grass L, Scorilas A, Diamandis EP, Katsaros D. Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma. International Journal of Cancer. Journal International Du Cancer. 106: 605-10. PMID 12845660 DOI: 10.1002/Ijc.11296 |
0.517 |
|
| 2003 |
Scorilas A, Chiang PM, Katsaros D, Yousef GM, Diamandis EP. Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors. Gene. 310: 79-89. PMID 12801635 DOI: 10.1016/S0378-1119(03)00499-2 |
0.551 |
|
| 2003 |
Luo LY, Yousef G, Diamandis EP. Human tissue kallikreins and testicular cancer. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 111: 225-32; discussion 2. PMID 12752266 DOI: 10.1034/J.1600-0463.2003.11101261.X |
0.564 |
|
| 2003 |
Nakamura T, Stephan C, Scorilas A, Yousef GM, Jung K, Diamandis EP. Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues. Urology. 61: 1042-6. PMID 12736044 DOI: 10.1016/S0090-4295(02)02443-3 |
0.506 |
|
| 2003 |
Yousef GM, Kopolovic AD, Elliott MB, Diamandis EP. Genomic overview of serine proteases. Biochemical and Biophysical Research Communications. 305: 28-36. PMID 12732192 DOI: 10.1016/S0006-291X(03)00638-7 |
0.342 |
|
| 2003 |
Yousef GM, Polymeris ME, Yacoub GM, Scorilas A, Soosaipillai A, Popalis C, Fracchioli S, Katsaros D, Diamandis EP. Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Research. 63: 2223-7. PMID 12727843 |
0.502 |
|
| 2003 |
Yousef GM, Scorilas A, Nakamura T, Ellatif MA, Ponzone R, Biglia N, Maggiorotto F, Roagna R, Sismondi P, Diamandis EP. The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. Breast Cancer Research and Treatment. 78: 149-58. PMID 12725415 DOI: 10.1023/A:1022931403825 |
0.557 |
|
| 2003 |
Hutchinson S, Luo LY, Yousef GM, Soosaipillai A, Diamandis EP. Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin. Clinical Chemistry. 49: 746-51. PMID 12709365 DOI: 10.1373/49.5.746 |
0.452 |
|
| 2003 |
Nakamura T, Scorilas A, Stephan C, Yousef GM, Kristiansen G, Jung K, Diamandis EP. Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues British Journal of Cancer. 88: 1101-1104. PMID 12671711 DOI: 10.1038/Sj.Bjc.6600869 |
0.513 |
|
| 2003 |
Yousef GM, Fracchioli S, Scorilas A, Borgoño CA, Iskander L, Puopolo M, Massobrio M, Diamandis EP, Katsaros D. Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer. American Journal of Clinical Pathology. 119: 346-55. PMID 12645335 DOI: 10.1309/0Ua57Mnayv0Mce9U |
0.544 |
|
| 2003 |
Diamandis EP, Scorilas A, Fracchioli S, Van Gramberen M, De Bruijn H, Henrik A, Soosaipillai A, Grass L, Yousef GM, Stenman UH, Massobrio M, Van Der Zee AGJ, Vergote I, Katsaros D. Human kallikrein 6 (hK6): A new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma Journal of Clinical Oncology. 21: 1035-1043. PMID 12637468 DOI: 10.1200/Jco.2003.02.022 |
0.455 |
|
| 2003 |
Kyriakopoulou LG, Yousef GM, Scorilas A, Katsaros D, Massobrio M, Fracchioli S, Diamandis EP. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer Clinical Biochemistry. 36: 135-143. PMID 12633763 DOI: 10.1016/S0009-9120(02)00446-0 |
0.535 |
|
| 2003 |
Yousef GM, Kishi T, Diamandis EP. Role of kallikrein enzymes in the central nervous system Clinica Chimica Acta. 329: 1-8. PMID 12589961 DOI: 10.1016/S0009-8981(03)00004-4 |
0.402 |
|
| 2003 |
Kapadia C, Chang A, Sotiropoulou G, Yousef GM, Grass L, Soosaipillai A, Xing X, Howarth DHC, Diamandis EP. Human kallikrein 13: Production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay Clinical Chemistry. 49: 77-86. PMID 12507963 DOI: 10.1373/49.1.77 |
0.51 |
|
| 2003 |
Stephan C, Yousef GM, Scorilas A, Jung K, Jung M, Kristiansen G, Hauptmann S, Bharaj BS, Nakamura T, Loening SA, Diamandis EP. Quantitative analysis of kallikrein 15 gene expression in prostate tissue Journal of Urology. 169: 361-364. PMID 12478190 |
0.477 |
|
| 2003 |
Yousef GM, Diamandis EP. Human kallikreins: Common structural features, sequence analysis and evolution Current Genomics. 4: 147-165. DOI: 10.2174/1389202033350074 |
0.529 |
|
| 2003 |
Okano K, Fukui M, Suehiro Y, Hamanaka Y, Imai K, Hinoda Y, Yousef GM, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Yang H, Liu VWS, Tsang PCK, Yip AMW, et al. Contents Vol. 24, 2003 Tumor Biology. 24: 329-330. DOI: 10.1159/000077138 |
0.336 |
|
| 2003 |
Okano K, Fukui M, Suehiro Y, Hamanaka Y, Imai K, Hinoda Y, Yousef GM, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Yang H, Liu VWS, Tsang PCK, Yip AMW, et al. Subject Index Vol. 24, 2003 Tumor Biology. 24: 327-328. DOI: 10.1159/000077137 |
0.342 |
|
| 2003 |
Katsaros D, Fracchioli S, de la Longrais IAR, Puopolo M, Yousef GM, Vergote I, van der Zee AG, Diamandis E. HUMAN KALLIKREINS (HKS) AS NOVEL SERUM BIOMARKERS IN OVARIAN CANCER International Journal of Gynecologic Cancer. 13: 19.2-20. DOI: 10.1136/Ijgc-00009577-200303001-00066 |
0.488 |
|
| 2003 |
Fracchioli S, Yousef GM, de la Longrais IAR, Puopolo M, Richiardi G, Danese S, Diamandis E, Katsaros D. HUMAN KALLIKREIN GENE 15 (KLK15) EXPRESSION International Journal of Gynecologic Cancer. 13: 19.1-19. DOI: 10.1136/Ijgc-00009577-200303001-00065 |
0.494 |
|
| 2003 |
Yousef G, Diamandis E. Tissue kallikreins: new players in normal and abnormal cell growth? Thrombosis and Haemostasis. 90: 7-16. DOI: 10.1055/S-0037-1613593 |
0.455 |
|
| 2003 |
STEPHAN C, YOUSEF GM, SCORILAS A, JUNG K, JUNG M, KRISTIANSEN G, HAUPTMANN S, BHARAJ BS, NAKAMURA T, LOENING SA, DIAMANDIS EP. Quantitative Analysis of Kallikrein 15 Gene Expression in Prostate Tissue Journal of Urology. 169: 361-364. DOI: 10.1016/S0022-5347(05)64127-4 |
0.467 |
|
| 2002 |
Yousef GM, Scorilas A, Magklara A, Memari N, Ponzone R, Sismondi P, Biglia N, Abd Ellatif M, Diamandis EP. The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer British Journal of Cancer. 87: 1294-1300. PMID 12439720 DOI: 10.1038/Sj.Bjc.6600590 |
0.553 |
|
| 2002 |
Yousef GM, Borgoño CA, Scorilas A, Ponzone R, Biglia N, Iskander L, Polymeris ME, Roagna R, Sismondi P, Diamandis EP. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis British Journal of Cancer. 87: 1287-1293. PMID 12439719 DOI: 10.1038/sj.bjc.6600623 |
0.476 |
|
| 2002 |
Yousef GM, Diamandis EP. Human tissue kallikreins: A new enzymatic cascade pathway? Biological Chemistry. 383: 1045-1057. PMID 12437087 DOI: 10.1515/Bc.2002.113 |
0.463 |
|
| 2002 |
Yousef GM, Obiezu CV, Jung K, Stephan C, Scorilas A, Diamandis EP. Differential expression of kallikrein gene 5 in cancerous and normal testicular tissues Urology. 60: 714-718. PMID 12385949 DOI: 10.1016/S0090-4295(02)01811-3 |
0.547 |
|
| 2002 |
Yousef GM, Diamandis EP. Expanded human tissue kallikrein family - A novel panel of cancer biomarkers Tumor Biology. 23: 185-192. PMID 12218299 DOI: 10.1159/000064027 |
0.515 |
|
| 2002 |
Yousef GM, Scorilas A, Kyriakopoulou LG, Rendl L, Diamandis M, Ponzone R, Biglia N, Giai M, Roagna R, Sismondi P, Diamandis EP. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: An independent indicator of poor prognosis in breast cancer Clinical Chemistry. 48: 1241-1250. PMID 12142380 |
0.477 |
|
| 2002 |
Diamandis EP, Yousef GM. Human tissue kallikreins: A family of new cancer biomarkers Clinical Chemistry. 48: 1198-1205. PMID 12142373 |
0.515 |
|
| 2002 |
Mahmoud AAH, Yousef GM, Al-Hifzi I, Diamandis EP. Cockayne syndrome in three sisters with varying clinical presentation American Journal of Medical Genetics. 111: 81-85. PMID 12124741 DOI: 10.1002/Ajmg.10492 |
0.379 |
|
| 2002 |
Yousef GM, Diamandis EP. Kallikreins, steroid hormones and ovarian cancer: is there a link? Minerva Endocrinologica. 27: 157-166. PMID 12091791 |
0.308 |
|
| 2002 |
Chang A, Yousef GM, Scorilas A, Grass L, Sismondi P, Ponzone R, Diamandis EP. Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: An independent indicator of favourable prognosis in breast cancer British Journal of Cancer. 86: 1457-1464. PMID 11986781 DOI: 10.1038/Sj.Bjc.6600283 |
0.5 |
|
| 2002 |
Yousef GM, Scorilas A, Chang A, Rendl L, Diamandis M, Jung K, Diamandis EP. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues Prostate. 51: 126-132. PMID 11948967 DOI: 10.1002/Pros.10067 |
0.573 |
|
| 2002 |
Yousef GM, Ordon MH, Foussias G, Diamandis EP. Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes Gene. 286: 259-270. PMID 11943481 DOI: 10.1016/S0378-1119(02)00432-8 |
0.395 |
|
| 2002 |
Yousef GM, Scorilas A, Kyriakopoulou LG, Rendl L, Diamandis M, Ponzone R, Biglia N, Giai M, Roagna R, Sismondi P, Diamandis EP. Human Kallikrein Gene 5 (KLK5) Expression by Quantitative PCR: An Independent Indicator of Poor Prognosis in Breast Cancer Clinical Chemistry. 48: 1241-1250. DOI: 10.1093/Clinchem/48.8.1241 |
0.539 |
|
| 2002 |
Diamandis EP, Yousef GM. Human Tissue Kallikreins: A Family of New Cancer Biomarkers Clinical Chemistry. 48: 1198-1205. DOI: 10.1093/Clinchem/48.8.1198 |
0.513 |
|
| 2001 |
Diamandis EP, Yousef GM. Human tissue kallikrein gene family: A rich source of novel disease biomarkers Expert Review of Molecular Diagnostics. 1: 182-190. PMID 11901813 DOI: 10.1586/14737159.1.2.182 |
0.476 |
|
| 2001 |
Chang A, Yousef GM, Jung K, Rajpert-De Meyts E, Diamandis EP. Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: Differential expression in the human testis and testicular cancer Anticancer Research. 21: 3147-3152. PMID 11848466 |
0.365 |
|
| 2001 |
Yousef GM, Kyriakopoulou LG, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick WJ, Richiardi G, Massobrio M, Diamandis EP, Katsaros D. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: A new independent and favorable prognostic marker Cancer Research. 61: 7811-7818. PMID 11691797 |
0.345 |
|
| 2001 |
Petraki CD, Karavana VN, Skoufogiannis PT, Little SP, Howarth DJC, Yousef GM, Diamandis EP. The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry Journal of Histochemistry and Cytochemistry. 49: 1431-1441. PMID 11668196 DOI: 10.1177/002215540104901111 |
0.518 |
|
| 2001 |
Shimizu-Okabe C, Yousef GM, Diamandis EP, Yoshida S, Shiosaka S, Fahnestock M. Expression of the kallikrein gene family in normal and Alzheimer's disease brain. Neuroreport. 12: 2747-51. PMID 11522960 DOI: 10.1097/00001756-200108280-00031 |
0.475 |
|
| 2001 |
Obiezu CV, Scorilas A, Katsaros D, Massobrio M, Yousef GM, Fracchioli S, Rigault de la Longrais IA, Arisio R, Diamandis EP. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients Clinical Cancer Research. 7: 2380-2386. PMID 11489816 |
0.388 |
|
| 2001 |
Yousef GM, Bharaj BS, Yu H, Poulopoulos J, Diamandis EP. Sequence analysis of the human kallikrein gene locus identifies a unique polymorphic minisatellite element. Biochemical and Biophysical Research Communications. 285: 1321-9. PMID 11478802 DOI: 10.1006/Bbrc.2001.5321 |
0.461 |
|
| 2001 |
Scorilas A, Yousef GM, Jung K, Meyts ERD, Carsten S, Diamandis EP. Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors Biochemical and Biophysical Research Communications. 285: 400-408. PMID 11444856 DOI: 10.1006/Bbrc.2001.5165 |
0.544 |
|
| 2001 |
Yousef GM, Diamandis M, Jung K, Diamandis EP. Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis. Genomics. 74: 385-95. PMID 11414767 DOI: 10.1006/Geno.2001.6556 |
0.519 |
|
| 2001 |
Yousef GM, Ordon MH, Foussias G, Diamandis EP. Molecular characterization, tissue expression, and mapping of a novel siglec-like gene (SLG2) with three splice variants Biochemical and Biophysical Research Communications. 284: 900-910. PMID 11409878 DOI: 10.1006/Bbrc.2001.5053 |
0.495 |
|
| 2001 |
Foussias G, Taylor SM, Yousef GM, Tropak MB, Ordon MH, Diamandis EP. Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs Biochemical and Biophysical Research Communications. 284: 887-899. PMID 11409877 DOI: 10.1006/Bbrc.2001.5052 |
0.479 |
|
| 2001 |
Scorilas A, Kyriakopoulou L, Yousef GM, Ashworth LK, Kwamie A, Diamandis EP. Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family Genomics. 72: 217-221. PMID 11401436 DOI: 10.1006/Geno.2000.6455 |
0.49 |
|
| 2001 |
Magklara A, Scorilas A, Katsaros D, Massobrio M, Yousef GM, Fracchioli S, Danese S, Diamandis EP. The human KLK8 (neuropsin/ovasin) gene: Identification of two novel splice variants and its prognostic value in ovarian cancer Clinical Cancer Research. 7: 806-811. PMID 11309326 |
0.374 |
|
| 2001 |
Yousef GM, Magklara A, Chang A, Jung K, Katsaros D, Diamandis EP. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies Cancer Research. 61: 3425-3431. PMID 11309303 |
0.331 |
|
| 2001 |
Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: Structure, function, and association to disease Endocrine Reviews. 22: 184-204. PMID 11294823 DOI: 10.1210/Edrv.22.2.0424 |
0.472 |
|
| 2001 |
Kim H, Scorilas A, Katsaros D, Yousef GM, Massobrio M, Fracchioli S, Piccinno R, Gordini G, Diamandis EP. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer British Journal of Cancer. 84: 643-650. PMID 11237385 DOI: 10.1054/Bjoc.2000.1649 |
0.561 |
|
| 2001 |
Yousef GM, Scorilas A, Jung K, Ashworth LK, Diamandis EP. Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer Journal of Biological Chemistry. 276: 53-61. PMID 11010966 DOI: 10.1074/Jbc.M005432200 |
0.474 |
|
| 2000 |
Diamandis EP, Yousef GM, Petraki C, Soosaipillai AR. Human kallikrein 6 as a biomarker of Alzheimer's disease Clinical Biochemistry. 33: 663-667. PMID 11166014 DOI: 10.1016/S0009-9120(00)00185-5 |
0.407 |
|
| 2000 |
Diamandis EP, Yousef GM, Soosaipillai AR, Bunting P. Human kallikrein 6 (zyme/protease M/neurosin): A new serum biomarker of ovarian carcinoma Clinical Biochemistry. 33: 579-583. PMID 11124344 DOI: 10.1016/S0009-9120(00)00182-X |
0.507 |
|
| 2000 |
Foussias G, Yousef GM, Diamandis EP. Molecular characterization of a Siglec8 variant containing cytoplasmic tyrosine-based motifs, and mapping of the Siglec8 gene Biochemical and Biophysical Research Communications. 278: 775-781. PMID 11095983 DOI: 10.1006/Bbrc.2000.3866 |
0.444 |
|
| 2000 |
Yousef GM, Magklara A, Diamandis EP. KLK12 is a novel serine protease and a new member of the human kallikrein gene family - Differential expression in breast cancer Genomics. 69: 331-341. PMID 11056051 DOI: 10.1006/Geno.2000.6346 |
0.513 |
|
| 2000 |
Diamandis EP, Yousef GM, Soosaipillai AR, Grass L, Porter A, Little S, Sotiropoulou G. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications Clinical Biochemistry. 33: 369-375. PMID 11018688 DOI: 10.1016/S0009-9120(00)00145-4 |
0.49 |
|
| 2000 |
Yousef GM, Chang A, Scorilas A, Diamandis EP. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4 Biochemical and Biophysical Research Communications. 276: 125-133. PMID 11006094 DOI: 10.1006/Bbrc.2000.3448 |
0.49 |
|
| 2000 |
Yousef GM, Scorilas A, Magklara A, Soosaipillai A, Diamandis EP. The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation. Gene. 254: 119-28. PMID 10974542 DOI: 10.1016/S0378-1119(00)00280-8 |
0.521 |
|
| 2000 |
Obiezu CV, Yousef G, Diamandis EP. Identification of exon 1 of prostase/KLK-L1 gene. Clinical Biochemistry. 33: 221-2. PMID 10913523 DOI: 10.1016/S0009-9120(00)00060-6 |
0.464 |
|
| 2000 |
Foussias G, Yousef GM, Diamandis EP. Identification and molecular characterization of a novel member of the siglec family (SIGLEC9). Genomics. 67: 171-8. PMID 10903842 DOI: 10.1006/Geno.2000.6208 |
0.486 |
|
| 2000 |
Yousef GM, Diamandis EP. The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9). Genomics. 65: 184-94. PMID 10783266 DOI: 10.1006/Geno.2000.6159 |
0.435 |
|
| 2000 |
Yousef GM, Chang A, Diamandis EP. Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues. The Journal of Biological Chemistry. 275: 11891-8. PMID 10766816 DOI: 10.1074/Jbc.275.16.11891 |
0.478 |
|
| 2000 |
Diamandis EP, Yousef GM, Luo LY, Magklara A, Obiezu CV. The new human kallikrein gene family: implications in carcinogenesis. Trends in Endocrinology and Metabolism: Tem. 11: 54-60. PMID 10675891 DOI: 10.1016/S1043-2760(99)00225-8 |
0.474 |
|
| 2000 |
Yousef GM, Scorilas A, Diamandis EP. Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family. Genomics. 63: 88-96. PMID 10662548 DOI: 10.1006/Geno.1999.6072 |
0.459 |
|
| 2000 |
Yousef GM, Diamandis EP. The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation. The Journal of Biological Chemistry. 274: 37511-6. PMID 10608802 DOI: 10.1074/Jbc.274.53.37511 |
0.45 |
|
| 2000 |
Diamandis EP, Yousef GM, Clements J, Ashworth LK, Yoshida S, Egelrud T, Nelson PS, Shiosaka S, Little S, Lilja H, Stenman U, Rittenhouse HG, Wain H. New Nomenclature for the Human Tissue Kallikrein Gene Family Clinical Chemistry. 46: 1855-1858. DOI: 10.1093/Clinchem/46.11.1855 |
0.534 |
|
| 2000 |
Yousef G, Diamandis E. The new human kallikrein gene family on chromosome 19Q13.3–Q13.4 and association to various tumours Clinical Biochemistry. 33: 242. DOI: 10.1016/S0009-9120(00)00135-1 |
0.461 |
|
| 2000 |
Kim H, Yousef G, Katsaros D, Diamandis E. Dramatic overexpression of the Kallikrein-like gene 2 (KLK-L2), in ovarian carcinomas Clinical Biochemistry. 33: 230. DOI: 10.1016/S0009-9120(00)00100-4 |
0.456 |
|
| 1999 |
Yousef GM, Luo LY, Scherer SW, Sotiropoulou G, Diamandis EP. Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease. Genomics. 62: 251-9. PMID 10610719 DOI: 10.1006/Geno.1999.6012 |
0.522 |
|
| Show low-probability matches. |